Stempel, Jonathan

Follow Stempel, Jonathan: Website |


Sanofi reaches $40M settlement over obesity drug linked to suicidal thoughts

Sanofi reaches $40M settlement over obesity drug linked to suicidal thoughts

September 20, 2013 5:10 pm by | 0 Comments

NEW YORK (Reuters) – Sanofi SA has reached a $40 million settlement of a U.S. lawsuit accusing the French drugmaker of misleading investors about the safety of a weight loss pill that a U.S. regulatory panel linked to suicidal thoughts.
The all-cash s…


Judge triples damages award: Zimmer to pay Stryker $228M in patent case

Judge triples damages award: Zimmer to pay Stryker $228M in patent case

August 9, 2013 11:56 am by | 0 Comments

(Reuters) – A federal judge ordered Zimmer Holdings Inc to pay Stryker Corp more than $228 million for infringing its surgical irrigation patents, and in doing so tripled a damages award by a jury that found Zimmer’s conduct was willful.
U.S. District…



Court voids drug rep’s conviction for off-label promotion, cites public’s right to know

Court voids drug rep’s conviction for off-label promotion, cites public’s right to know

December 4, 2012 7:11 am by | 1 Comments

NEW YORK (Reuters) – A divided federal appeals court on Monday threw out the conviction of a sales representative for promoting off-label use of a prescription drug, a ruling that could make it harder for the government to police how drugs are markete…


Pfizer to pay $67.5 million in investor lawsuit over Pristiq

Pfizer to pay $67.5 million in investor lawsuit over Pristiq

November 12, 2012 9:46 am by | 0 Comments

NEW YORK (Reuters) – Pfizer Inc agreed to pay $67.5 million to settle a class-action lawsuit by former Wyeth Inc shareholders who said they were misled about risks associated with the antidepressant Pristiq.
The all-cash settlement was disclosed on Fr…


Union pension fund wins class-action status for lawsuit over anti-depressant Pristiq

Union pension fund wins class-action status for lawsuit over anti-depressant Pristiq

September 18, 2012 10:14 am by | 0 Comments

(Reuters) – A federal judge has granted class-action status to former Wyeth Inc shareholders who accused the company, now part of Pfizer Inc, of misleading them about risks associated with the antidepressant Pristiq.
The decision issued Tuesday by U.S…